Archive: NIH Roadmap Epigenomics Program NIH Roadmap Epigenome Mapping Center

Center director and principal investigator: Joe Costello, PhD, UCSF. Associate professor of neurological surgery, Karen Osney Brownstein Endowed Chair in Molecular Neuro-Oncology and director of the epigenetics division of the UCSF Cell Cycling and Signaling Program. Co-director: Marco Marra, PhD, British Columbia Cancer Agency Genome Sciences Centre. Professor of medical genetics, University of British Columbia; director of the British Columbia Cancer Agency Genome Sciences Centre in Vancouver. Co-investigator: Steven Jones, PhD, British Columbia Cancer Agency Genome Sciences Centre. Associate director/Head Bioinformatics, British Columbia Cancer Agency Genome Sciences Centre; assistant professor at Simon Fraser University. Co-investigator: Martin Hirst, PhD, British Columbia Cancer Agency Genome Sciences Centre. Functional Genomics platform leader, adjunct professor of molecular biology and biochemistry at Simon Fraser University. Co-investigator: Peggy Farnham, PhD, UC Davis. Professor of pharmacology, associate director of genomics at UC Davis Genome Center and faculty director of Expression Analysis Core. Co-investigator: David Haussler, PhD, UC Santa Cruz. Howard Hughes Medical Institute investigator, director of the Center for Biomolecular Science and Engineering, and professor of biomolecular engineering; scientific co-director, California Institute for Quantitative Biosciences (QB3). Co-investigator: James Kent, PhD, UC Santa Cruz. Research scientist. Co-investigator: Ting Wang, PhD, UC Santa Cruz. Postdoctoral scholar. Co-investigator: Arturo Alvarez-Buylla, PhD, UCSF. Heather and Melanie Muss Endowed Chair, professor of neurological surgery. Co-investigator: Susan Fisher, PhD, UCSF. professor and head, Human Embryonic Stem Cell Research Center. Co-investigator: Michael McManus, PhD, UCSF. Assistant professor, Diabetes Center, and director of W.M. Keck Center for Noncoding RNAs. Co-investigator: Thea Tlsty, PhD, UCSF. Professor of pathology and director of Cell Cycling and Signaling Program. Co-investigator: Arthur Weiss, MD, PhD, UCSF. Howard Hughes Medical Institute investigator, Ephraim P. Engleman Distinguished Professor and chief of Division of Rheumatology.